| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 02/12/2003 | EP1283202A1 Method for preparing heterocyclic-carboxylic acids |
| 02/12/2003 | EP1283055A1 Soluble beta amyloid precursor protein secretion promoters |
| 02/12/2003 | EP1282630A1 Hydroxylamine esters as polymerization initiators |
| 02/12/2003 | EP1282609A2 Piperazinedione compounds |
| 02/12/2003 | EP1282608A1 Production of 2-ethyl-3-methyl-1,4-diazine |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282595A1 Novel phenyl-propargylether derivatives |
| 02/12/2003 | EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | CA2274597C Process for producing halogenated heteroaryl compounds |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010146A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030028021 Chemical compounds |
| 02/06/2003 | US20030027902 Piperazinone derivatives |
| 02/06/2003 | US20030027829 Potassium channel inhibitors |
| 02/06/2003 | US20030027828 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/05/2003 | EP1280809A1 Antitumoral ecteinascidin derivatives |
| 02/05/2003 | EP1280797A1 Inhibitors of dipeptidyl peptidase iv |
| 02/05/2003 | EP1280523A2 Use of benzamide derivatives for the treatment of high ocular tension and glaucoma |
| 02/05/2003 | EP1082121A4 Hiv integrase inhibitors |
| 02/05/2003 | EP0742201B1 Process for producing aromatic or heteroaromatic sulfur compounds |
| 02/05/2003 | CN1395563A Isatine derivatives with neurotrophic activity |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100765C Process for preapring tetramethyl pyrazine |
| 02/05/2003 | CN1100760C Process for preparation of arylamides of heteroarometic carboxylic acids |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515159 S,S-ethylenediamine-N,N′-disuccinic acid iron alkali salt and a process for production thereof |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |
| 01/30/2003 | WO2003007959A1 Quinoxaline derivatives which have parp inhibitory action |
| 01/30/2003 | WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | WO2003007957A1 Method and composition for treatment of cancer |
| 01/30/2003 | US20030022935 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents |
| 01/30/2003 | US20030022904 Pyrazine compounds |
| 01/30/2003 | US20030022903 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/30/2003 | US20030022902 Based upon 2-(N-(7-benzyl-9-methyl-1,5-dioxonan-2,6-dione-3-yl)amido)-3-hydroxy-4 -methoxypyridine; use as agricultural fungicide |
| 01/30/2003 | US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula |
| 01/30/2003 | CA2454007A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | CA2453993A1 Method and composition for treatment of cancer |
| 01/29/2003 | EP1279668A1 Methods for preparing 5- and 6-benzyl functionalized quinoxalines |
| 01/29/2003 | EP1278721A1 Process for the preparation of pyrazine compounds |
| 01/29/2003 | EP0888319B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 01/23/2003 | WO2003006459A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018052 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/23/2003 | US20030018035 Central nervous system disorders |
| 01/23/2003 | US20030018033 Antiinflammatory agents; immunology; autoimmune diseases; rheumatic diseases |
| 01/23/2003 | US20030018012 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2446726A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 01/22/2003 | EP1277742A1 Method for preparing halomethyl heterocyclic compounds |
| 01/22/2003 | EP1277739A1 Method for preparing heterocyclic-carboxylic acids |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276732A1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 01/22/2003 | EP0646115B1 Heterocyclic-cyclic amine derivatives |
| 01/22/2003 | CN1392143A Process for preparing 5-methyl pyrazine-2-carboxylic acid |
| 01/21/2003 | US6509337 A method of treating a mammalian disease condition mediated by metalloproteinase activity which comprises administering to a mammal in need thereof a therapeutically effective amount of a compound as defined in claim 1 or a pharmaceutically |
| 01/21/2003 | US6508753 Chiral ligands for asymmetric catalysis |
| 01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
| 01/16/2003 | WO2003004475A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004474A1 Pesticidally active aminoacetonitriles |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004458A1 New compounds |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 01/16/2003 | US20030013714 Sleep disorders; eating disorders; sexual disorders; hypotensive agents |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | US20030013706 Autoimmune disease; antiinflammatory agents |
| 01/16/2003 | US20030013641 Complexing drug with diketopiperazine; washing; separation of impurities |
| 01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/15/2003 | EP1275647A1 Octahydro-2H-pyrido[1,2-a]pyrazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1274693A1 Method for producing 2,5-diketopiperazines, 2,5-diketopiperazines, dipeptides and the use thereof |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0907643B1 Compounds with growth hormone releasing properties |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391564A Chemical compounds |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1098842C Organic second nonlinear optic response chromophore compound |
| 01/14/2003 | US6506761 Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| 01/14/2003 | US6506760 Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | US6506517 Surface modified carbonaceous materials |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002255A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/09/2003 | WO2002009762A3 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 01/09/2003 | WO2001072728B1 Novel piperazine derivatives |
| 01/09/2003 | US20030009033 Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/09/2003 | US20030008882 Proteomimetic compounds and methods |
| 01/08/2003 | EP1272492A2 Method for producing triethylene diamine, using ethylene diamine |
| 01/08/2003 | EP1272479A2 Novel compounds for enhancing chemotherapy |